Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016 - Sorbonne Université Access content directly
Journal Articles Journal of Rheumatology Year : 2017

Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016

Maarten de Wit
  • Function : Author
Philip J. Mease
  • Function : Author
Kristina Callis Duffin
  • Function : Author
Musaab Elmamoun
  • Function : Author
William Tillett
  • Function : Author
Willemina Campbell
  • Function : Author
Oliver Fitzgerald
  • Function : Author
Dafna D. Gladman
  • Function : Author
Pil Hoejgaard
  • Function : Author
Ying Ying Leung
  • Function : Author
Chris Lindsay
  • Function : Author
Désirée M. van Der Heijde
  • Function : Author
Bev Shea
  • Function : Author
Laura Coates
  • Function : Author
Lihi Eder
  • Function : Author
Neil Mchugh
  • Function : Author
Ingrid Steinkoenig
  • Function : Author

Abstract

Objective. To include the patient perspective in accordance with the Outcome Measures in Rheumatology (OMERACT) Filter 2.0 in the updated Psoriatic Arthritis (PsA) Core Domain Set for randomized controlled trials (RCT) and longitudinal observational studies (LOS). Methods. At OMERACT 2016, research conducted to update the PsA Core Domain Set was presented and discussed in breakout groups. The updated PsA Core Domain Set was voted on and endorsed by OMERACT participants. Results. We conducted a systematic literature review of domains measured in PsA RCT and LOS, and identified 24 domains. We conducted 24 focus groups with 130 patients from 7 countries representing 5 continents to identify patient domains. We achieved consensus through 2 rounds of separate surveys with 50 patients and 75 physicians, and a nominal group technique meeting with 12 patients and 12 physicians. We conducted a workshop and breakout groups at OMERACT 2016 in which findings were presented and discussed. The updated PsA Core Domain Set endorsed with 90% agreement by OMERACT 2016 participants included musculoskeletal disease activity, skin disease activity, fatigue, pain, patient's global assessment, physical function, health-related quality of life, and systemic inflammation, which were recommended for all RCT and LOS. These were important, but not required in all RCT and LOS: economic cost, emotional well-being, participation, and structural damage. Independence, sleep, stiffness, and treatment burden were on the research agenda. Conclusion. The updated PsA Core Domain Set was endorsed at OMERACT 2016. Next steps for the PsA working group include evaluation of PsA outcome measures and development of a PsA Core Outcome Measurement Set.
Fichier principal
Vignette du fichier
nihms843793.pdf (354.38 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-03879084 , version 1 (30-04-2024)

Identifiers

Cite

Ana-Maria Orbai, Maarten de Wit, Philip J. Mease, Kristina Callis Duffin, Musaab Elmamoun, et al.. Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016. Journal of Rheumatology, 2017, 44 (10), pp.1522--1528. ⟨10.3899/jrheum.160904⟩. ⟨hal-03879084⟩
6 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More